Skip to Content

Publications Search - Abstract View

Title: Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.
Authors: Gremer L,  Merbitz-Zahradnik T,  Dvorsky R,  Cirstea IC,  Kratz CP,  Zenker M,  Wittinghofer A,  Ahmadian MR
Journal: Hum Mutat
Date: 2011 Jan
Branches: CGB
PubMed ID: 20949621
PMC ID: PMC3117284
Abstract: The KRAS gene is the most common locus for somatic gain-of-function mutations in human cancer. Germline KRAS mutations were shown recently to be associated with developmental disorders, including Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS). The molecular basis of this broad phenotypic variability has in part remained elusive so far. Here, we comprehensively analyzed the biochemical and structural features of ten germline KRAS mutations using physical and cellular biochemistry. According to their distinct biochemical and structural alterations, the mutants can be grouped into five distinct classes, four of which markedly differ from RAS oncoproteins. Investigated functional alterations comprise the enhancement of intrinsic and guanine nucleotide exchange factor (GEF) catalyzed nucleotide exchange, which is alternatively accompanied by an impaired GTPase-activating protein (GAP) stimulated GTP hydrolysis, an overall loss of functional properties, and a deficiency in effector interaction. In conclusion, our data underscore the important role of RAS in the pathogenesis of the group of related disorders including NS, CFCS, and CS, and provide clues to the high phenotypic variability of patients with germline KRAS mutations.